Cochrane · systematic review · CD012863
Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage cervical cancer
Aue-aungkul, A, Kietpeerakool, C, Rattanakanokchai, S, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library
Gynaecological, Neuro-oncology and Orphan CancerAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
14
current version
GRADE rated
3
No studies
11
Included studies
NR
No studies 11 · 78.6%Ungraded 0 · 0%Very low 3 · 21.4%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Bethanechol compared to placebo for preventing bladder dysfunction after radical hysterectomy in women with early‐stage cervical cancer
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Rate of spontaneous voiding recovery 1 week after surgery Bethanechol vs placebo | no estimate extracted | NR | No studies |
Quality of life (QoL) Bethanechol vs placebo | no estimate extracted | NR | No studies |
Time after surgery to post‐void residual volume of urine ≤ 50 mL (days) Bethanechol vs placebo | no estimate extracted | NR | No studies |
Adverse events Bethanechol vs placebo | no estimate extracted | NR | No studies |
Post‐void residual urine volume (mL) at 1 month after surgery Bethanechol vs placebo | no estimate extracted | 1 study · 39 participants | Very low Downgraded: risk of bias, imprecision |
Urinary tract infections in the first month after surgery Bethanechol vs placebo | no estimate extracted | NR | No studies |
Subjective urinary symptoms Bethanechol vs placebo | no estimate extracted | NR | No studies |
Suprapubic catheterisation compared to intermittent self‐catheterisation for preventing bladder dysfunction after radical hysterectomy in women with early‐stage cervical cancer
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Rate of spontaneous voiding recovery 1 week after surgery Suprapubic catheterisation vs intermittent self‐catheterisation | no estimate extracted | NR | No studies |
Quality of life (QoL) Suprapubic catheterisation vs intermittent self‐catheterisation | no estimate extracted | NR | No studies |
Time after surgery to post‐void residual volume of urine ≤ 50 mL (days) Suprapubic catheterisation vs intermittent self‐catheterisation | no estimate extracted | NR | No studies |
Adverse events (acute complication after surgery) Suprapubic catheterisation vs intermittent self‐catheterisation | RR 0.77 [0.24, 2.49] | 1 study · 71 participants | Very low Downgraded: imprecision, indirectness |
Post‐void residual urine volume (mL) at 1 month after surgery Suprapubic catheterisation vs intermittent self‐catheterisation | no estimate extracted | NR | No studies |
Urinary tract infections in the first month after surgery Suprapubic catheterisation vs intermittent self‐catheterisation | RR 0.77 [0.53, 1.13] | 2 studies · 95 participants | Very low Downgraded: risk of bias, imprecision |
Subjective urinary symptoms Suprapubic catheterisation vs intermittent self‐catheterisation | no estimate extracted | NR | No studies |